-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
AbCellera Biologics (NASDAQ:ABCL) Reaches New 52-Week Low on Analyst Downgrade
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) hit a new 52-week low during mid-day trading on Saturday after Stifel Nicolaus lowered their price target on the stock from $12.00 to $10.00. Stifel Nicolaus currently has a buy rating on the stock. AbCellera Biologics traded as low as $2.31 and last traded at $2.59, with […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) hit a new 52-week low during mid-day trading on Saturday after Stifel Nicolaus lowered their price target on the stock from $12.00 to $10.00. Stifel Nicolaus currently has a buy rating on the stock. AbCellera Biologics traded as low as $2.31 and last traded at $2.59, with […]
